471905-41-6,MFCD21608529
Catalog No.:AA00DB40

471905-41-6 | MK-0752

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$98.00   $68.00
- +
5mg
98% by HPLC
in stock  
$224.00   $157.00
- +
100mg
95%
in stock  
$270.00   $189.00
- +
250mg
95%
in stock  
$446.00   $312.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DB40
Chemical Name:
MK-0752
CAS Number:
471905-41-6
Molecular Formula:
C21H21ClF2O4S
Molecular Weight:
442.9038
MDL Number:
MFCD21608529
SMILES:
OC(=O)CC[C@@H]1CC[C@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(cc1)Cl
Properties
Computed Properties
 
Complexity:
665  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
6  
XLogP3:
4.7  

Downstream Synthesis Route

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

942296-40-4    471905-41-6   
trans-3-4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexylpropanoicacid 

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[1]JournalofOrganicChemistry,2007,vol.72,p.4864-4871

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

Literature

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters 20130801

Title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910

Title: Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100901

Title: Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215

Title: Cook JJ, et al. Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci. 2010;30(19):6743-6750.

Title: Krop I, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30(19):2307-2313.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:471905-41-6 Molecular Formula|471905-41-6 MDL|471905-41-6 SMILES|471905-41-6 MK-0752
Catalog No.: AA00DB40
471905-41-6,MFCD21608529
471905-41-6 | MK-0752
Pack Size: 1mg
Purity: ≥98%
in stock
$98.00 $68.00
Pack Size: 5mg
Purity: 98% by HPLC
in stock
$224.00 $157.00
Pack Size: 100mg
Purity: 95%
in stock
$270.00 $189.00
Pack Size: 250mg
Purity: 95%
in stock
$446.00 $312.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DB40
Chemical Name: MK-0752
CAS Number: 471905-41-6
Molecular Formula: C21H21ClF2O4S
Molecular Weight: 442.9038
MDL Number: MFCD21608529
SMILES: OC(=O)CC[C@@H]1CC[C@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(cc1)Cl
Properties
Complexity: 665  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 29  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 6  
XLogP3: 4.7  
Downstream Synthesis Route
656810-86-5    471905-41-6 

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

942296-40-4    471905-41-6   
trans-3-4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexylpropanoicacid 

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

863605-38-3    471905-41-6 

[1]JournalofOrganicChemistry,2007,vol.72,p.4864-4871

470716-52-0    471905-41-6 

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

470716-51-9    471905-41-6 

[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155

Literature fold

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters20130801

Title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology20110910

Title: Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20100901

Title: Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20080215

Title: Cook JJ, et al. Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci. 2010;30(19):6743-6750.

Title: Krop I, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30(19):2307-2313.

Building Blocks More >
465-16-7
465-16-7
OLEANDRIN
AA00DB8A | MFCD26960889
52423-62-8
52423-62-8
2-Bromo-1-cyclopentylethanone
AA00DBD6 | MFCD15526808
52117-13-2
52117-13-2
N-(alpha,alpha-dimethylphenethyl)formamide
AA00DBIV | MFCD03265766
535934-25-9
535934-25-9
1-Bromo-2-chloro-4-iodobenzene
AA00DBPZ | MFCD04973904
4721-22-6
4721-22-6
1,6-Hexanebisphosphonic acid
AA00DBW9 | MFCD01630742
433920-97-9
433920-97-9
4-(5-Nitropyridin-2-yl)benzaldehyde
AA00DC41 | MFCD05864831
489-86-1
489-86-1
(-)-GUAIOL
AA00DCB3 | MFCD00043336
51830-53-6
51830-53-6
Benzo[b]thiophen-7-ylmethanol
AA00DCIR | MFCD08572209
4928-43-2
4928-43-2
N2,N2-Dimethyl-2,5-pyridinediamine
AA00DCMI | MFCD08691371
51884-11-8
51884-11-8
5-(4-Methylphenyl)-4h-1,2,4-triazol-3-amine
AA00DCR6 | MFCD00461061
Submit
© 2017 AA BLOCKS, INC. All rights reserved.